Carnegie Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARNEGIE
CARNEGIE has fifteen approved drugs.
Summary for Carnegie
| US Patents: | 0 |
| Tradenames: | 14 |
| Ingredients: | 10 |
| NDAs: | 15 |
Drugs and US Patents for Carnegie
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carnegie | BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 219422-001 | Apr 3, 2025 | AB | RX | No | No | ⤷ Try for Free | |||||
| Carnegie | E.E.S. 400 | erythromycin ethylsuccinate | TABLET;ORAL | 061905-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ||||||
| Carnegie | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-003 | Mar 29, 1982 | AB | RX | No | No | ⤷ Try for Free | |||||
| Carnegie | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try for Free | |||||
| Carnegie | ERYPED | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-003 | Mar 30, 1987 | AB | RX | Yes | No | ⤷ Try for Free | |||||
| Carnegie | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 202077-001 | Feb 11, 2013 | DISCN | No | No | ⤷ Try for Free | ||||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. |
Showing 1 to 6 of 6 entries
